These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21057160)

  • 21. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
    Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats.
    R Ebrahim A; El-Mesery M; El-Karef A; Eissa LA
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1218-1225. PubMed ID: 30205014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].
    Gao J; Li JS; Xu GL; Jia WD; Ma JL; Yu JH; Ge YS
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):900-4. PubMed ID: 21205474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
    Behari J; Zeng G; Otruba W; Thompson MD; Muller P; Micsenyi A; Sekhon SS; Leoni L; Monga SP
    J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
    Yang L; Wu D; Luo K; Wu S; Wu P
    Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
    Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
    Chu TH; Chan HH; Hu TH; Wang EM; Ma YL; Huang SC; Wu JC; Chang YC; Weng WT; Wen ZH; Wu DC; Chen YA; Tai MH
    Cancer Med; 2018 Jun; 7(6):2567-2580. PubMed ID: 29683262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
    Cervello M; Bachvarov D; Cusimano A; Sardina F; Azzolina A; Lampiasi N; Giannitrapani L; McCubrey JA; Montalto G
    OMICS; 2011 Jun; 15(6):383-92. PubMed ID: 21410330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
    Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
    World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on the proliferation of hepatocellular carcinoma cells].
    Tang BD; Zhou Q; Lin QH; Liu SC
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1511-3. PubMed ID: 17959527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells.
    Cusimano A; Azzolina A; Iovanna JL; Bachvarov D; McCubrey JA; D'Alessandro N; Montalto G; Cervello M
    Cell Cycle; 2010 Apr; 9(7):1399-410. PubMed ID: 20305374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
    Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
    Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C
    Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.
    Wilgus TA; Breza TS; Tober KL; Oberyszyn TM
    J Invest Dermatol; 2004 Jun; 122(6):1488-94. PubMed ID: 15175041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cyclooxygenase-2 inhibitor celecoxib attenuates hepatocellular carcinoma growth and c-Met expression in an orthotopic mouse model.
    Yin J; Liu B; Li B; Liu Z; Xie X; Lv Z; Gao S; Guang J
    Oncol Res; 2011; 19(3-4):131-9. PubMed ID: 21473289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.